Investors sold shares of Express Scripts Holding Co. (NASDAQ:ESRX) on strength during trading hours on Friday. $70.84 million flowed into the stock on the tick-up and $89.78 million flowed out of the stock on the tick-down, for a money net flow of $18.94 million out of the stock. Of all companies tracked, Express Scripts Holding had the 0th highest net out-flow for the day. Express Scripts Holding traded up $0.57 for the day and closed at $72.31

Several research analysts have weighed in on ESRX shares. Zacks Investment Research lowered shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a report on Thursday, August 4th. Barclays PLC raised their price objective on shares of Express Scripts Holding from $85.00 to $87.00 and gave the stock an “overweight” rating in a report on Wednesday, July 27th. Citigroup Inc. reaffirmed a “buy” rating on shares of Express Scripts Holding in a report on Tuesday, May 24th. Sanford C. Bernstein assumed coverage on shares of Express Scripts Holding in a report on Thursday, June 16th. They issued an “underperform” rating and a $68.00 price target for the company. Finally, Bank of America Corp. reaffirmed a “neutral” rating and issued a $82.00 price target on shares of Express Scripts Holding in a report on Tuesday, June 7th. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $81.26.

The stock has a market cap of $45.57 billion and a price-to-earnings ratio of 17.87. The firm has a 50-day moving average of $76.98 and a 200-day moving average of $73.35.

Express Scripts Holding (NASDAQ:ESRX) last posted its earnings results on Monday, July 25th. The company reported $1.57 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.57. The firm earned $25.20 billion during the quarter, compared to the consensus estimate of $25.42 billion. During the same period in the previous year, the company posted $1.44 EPS. The firm’s revenue for the quarter was down .9% compared to the same quarter last year. On average, analysts predict that Express Scripts Holding Co. will post $6.38 EPS for the current year.

Several large investors have recently bought and sold shares of the company. Bronfman E.L. Rothschild L.P. purchased a new stake in Express Scripts Holding during the fourth quarter valued at $1,316,000. Argent Trust Co increased its position in shares of Express Scripts Holding by 7.2% in the third quarter. Argent Trust Co now owns 16,596 shares of the company’s stock valued at $1,344,000 after buying an additional 1,110 shares during the period. Trexquant Investment LP bought a new position in shares of Express Scripts Holding during the fourth quarter valued at about $1,941,000. TrimTabs Asset Management LLC increased its position in shares of Express Scripts Holding by 1.9% in the fourth quarter. TrimTabs Asset Management LLC now owns 25,886 shares of the company’s stock valued at $2,263,000 after buying an additional 483 shares during the period. Finally, Parsons Capital Management Inc. RI increased its position in shares of Express Scripts Holding by 1.0% in the fourth quarter. Parsons Capital Management Inc. RI now owns 33,337 shares of the company’s stock valued at $2,914,000 after buying an additional 345 shares during the period.

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.